Project Grant HT94252410976
Award Date
9/30/24
Completion Date
9/29/28
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Plandome, NY 11030, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $299,937.00 to The Feinstein Institutes For Medical Research to conduct research on visualizing neural synaptic density in systemic lupus erythematosus (SLE) to better understand mechanisms of brain dysfunction. The award period runs from July 15, 2024 to July 14, 2026. The Feinstein Institutes, a non-profit research organization, will utilize this...
The federal Project Grant award, totaling $999,972.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Feinstein Institutes For Medical Research. The grant supports a study focused on "Studying Urine Macrophages in Lupus Nephritis to Shed Light on Kidney Disease Processes." The research aims to advance the understanding of lupus nephritis, a serious kidney condition, by examining immune cells in urine samples....
This $997,821 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research into the pathogenic role of neutrophil subpopulations in lupus nephritis. The primary awardee is Trustees of Dartmouth College, with sub-awards to The Johns Hopkins University and Dartmouth-Hitchcock Clinic. This multi-institutional effort will investigate the underlying mechanisms of neutrophil-driven pathology in lupus nephritis, with...
The Department of Defense's Military Medical Research and Development (CFDA 12.420) program awarded a $300,000 Project Grant to Duke University to investigate the "Complement-Activating Properties of Anti-Sm/RNP Antibodies in SLE". This 2-year research effort, starting on September 1, 2024 and ending on August 31, 2026, aims to advance biomedical research that can transform healthcare for military service members, veterans, and the broader public. The Military Medical Research and...
The federal Project Grant award of $654,367.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant, awarded on January 1, 2025, supports research to investigate the neural mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 (PASC), also known as "Long COVID". The research aims to determine the relationship...
The University of Houston was awarded a $750,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into interleukin-15 (IL-15) in lupus from September 30, 2021 through September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative...
This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
The U.S. Department of Defense's Defense Health Agency awarded a $749,999 Project Grant to the University of Louisville's Office of Research & Innovation to support the "RESTORATION OF MACROPHAGE FUNCTION AS A STRATEGY TO PREVENT/TREAT LUPUS" research project. The grant, which runs from September 1, 2023 to August 31, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420). This program supports a range of biomedical research aimed at...
This $462,131 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports transformative behavioral health research to improve quality of life for individuals with childhood-onset lupus. The prime awardee, The Hospital for Sick Children (Sick Kids Hospital) in Toronto, Canada, will lead this 4-year initiative. As a leading pediatric research hospital, Sick Kids Hospital has extensive experience as a subcontractor on...
This Project Grant award of $2,037,497.00 from the Defense Health Agency was made to Michigan State University on September 30, 2023. The purpose of the grant is to transform behavioral health care to improve the quality of life for individuals with childhood-onset lupus. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public. As...